News
My final reason for buying more Pfizer stock is that I'll get paid nicely to wait and see if the drugmaker lives up to Wall Street's growth outlook. Pfizer's forward dividend yield currently stands at ...
Pfizer Australia's Managing Director Anne Harris discusses the Vinnies CEO Sleepout fundraiser for homelessness in Australia.
Ahead of their graduation earlier this month, two Lake Forest High School students received national recognition for the ...
U.S. pharmaceutical firms are ramping up licensing deals with Chinese biotech companies, aiming to fill pipelines as major drug patents near expiration.
The recent experience of Chinese biotech companies in developing their own drug candidates and inking deals with larger ...
During the Covid-19 pandemic, South African and Colombian civil society organisations initiated strategic litigation against their governments to gain transparency on confidential vaccine contracts ...
Residents living near Port of Cork are in for a surprise this Friday, as a loud warning siren is set to blare across ...
After months of waking up with headaches, Claire visited her GP. Her life was turned upside down as doctors discovered what ...
Trump's NIH cuts are gutting university labs that fuel Big Pharma's drug pipeline and pushing U.S. biotech jobs, research, ...
US drugmakers are betting they can turn upfront payments of as little as $80 million into multibillion-dollar treatments.
The president wants foreign countries to pay more for drugs made in the US to help Big Pharma firms make more money abroad.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results